Sacubitril/valsartan reduces proteasome activation and cardiomyocyte area in an experimental mouse model of hypertrophy.
Meyer-Jens M, Wenzel K, Grube K, Rüdebusch J, Krämer E, Bahls M, Müller K, Voß H, Schlüter H, Felix SB, Carrier L, Könemann S, Schlossarek S.
Meyer-Jens M, et al. Among authors: muller k.
J Mol Cell Cardiol Plus. 2024 Jan 7;7:100059. doi: 10.1016/j.jmccpl.2023.100059. eCollection 2024 Mar.
J Mol Cell Cardiol Plus. 2024.
PMID: 39802437
Free PMC article.